Sanofi Expands Its Operations In Poland, USA

28 July 1996

French pharmaceutical company Sanofi made two international forays last week, to bolster its operations in Poland and in the USA.

In Poland, Sanofi has signed a joint-venture agreement with Biocom, the country's largest private pharmaceutical group, which has a strong presence in the areas of cardiology and central nervous system disorders.

The JV, to be called Sanofi Biocom, will be equally-owned by the two partners, and will hold a majority stake in Farmacom, a JV with the state-owned Polfa, which has a strong position in respiratory disease therapy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight